1. Home
  2. ALNY
  3. ALNY News

Latest Alnylam Pharmaceuticals Inc. (ALNY) News on April 19, 2025

ALNY

MT Newswires

2 days ago

BofA Adjusts Price Target on Alnylam Pharmaceuticals to $328 From $325, Keeps Buy Rating

Alnylam to Webcast Conference Call Discussing First Quarter 2025 Financial Results
ALNY

Business Wire

2 days ago

Alnylam to Webcast Conference Call Discussing First Quarter 2025 Financial Results

Is Alnylam Pharmaceuticals, Inc. (ALNY) the Best Growth Stock to Buy According to Billionaires?
ALNY

Insider Monkey

5 days ago

Is Alnylam Pharmaceuticals, Inc. (ALNY) the Best Growth Stock to Buy According to Billionaires?

High Growth Tech Stocks In US With Potential For Expansion
ALNY

Simply Wall St.

5 days ago

High Growth Tech Stocks In US With Potential For Expansion

How to Play the Biotech Meltdown in the Age of RFK Jr. and Tariffs
ALNY

The Wall Street Journal

8 days ago

How to Play the Biotech Meltdown in the Age of RFK Jr. and Tariffs

Alnylam (ALNY) Moves 8.5% Higher: Will This Strength Last?
ALNY

Zacks

9 days ago

Alnylam (ALNY) Moves 8.5% Higher: Will This Strength Last?

Seeking Recession-Proof Stocks? RBC Suggests 2 Healthcare Stocks to Buy
ALNY

TipRanks

9 days ago

Seeking Recession-Proof Stocks? RBC Suggests 2 Healthcare Stocks to Buy

Is Alnylam Pharmaceuticals, Inc. (ALNY) the Best Long Term Growth Stock to Buy According to Billionaires?
ALNY

Insider Monkey

11 days ago

Is Alnylam Pharmaceuticals, Inc. (ALNY) the Best Long Term Growth Stock to Buy According to Billionaires?

ALNY

Morningstar Research

15 days ago

Analyst Report: Alnylam Pharmaceuticals, Inc.

SNY Gets FDA Nod for First Ever Hemophilia Drug in the United States
ALNY

Zacks

18 days ago

SNY Gets FDA Nod for First Ever Hemophilia Drug in the United States

Alnylam to Webcast Presentation at Needham 24th Annual Virtual Healthcare Conference
ALNY

Business Wire

18 days ago

Alnylam to Webcast Presentation at Needham 24th Annual Virtual Healthcare Conference

ALNY

MT Newswires

19 days ago

Alnylam Pharmaceuticals' Qfitlia Approved by FDA for Hemophilia A, B Treatment

Alnylam Pharmaceuticals (NasdaqGS:ALNY) Celebrates FDA Approval of Qfitlia Despite 5% Share Price Dip
ALNY

Simply Wall St.

21 days ago

Alnylam Pharmaceuticals (NasdaqGS:ALNY) Celebrates FDA Approval of Qfitlia Despite 5% Share Price Dip

Alnylam Presents New Data from the HELIOS-B Phase 3 Study of Vutrisiran in Patients with ATTR Amyloidosis with Cardiomyopathy (ATTR-CM) at the American College of Cardiology’s Annual Scientific Session 2025
ALNY

Business Wire

21 days ago

Alnylam Presents New Data from the HELIOS-B Phase 3 Study of Vutrisiran in Patients with ATTR Amyloidosis with Cardiomyopathy (ATTR-CM) at the American College of Cardiology’s Annual Scientific Session 2025

Sarepta Therapeutics (SRPT) Down 30.3% Since Last Earnings Report: Can It Rebound?
ALNY

Zacks

22 days ago

Sarepta Therapeutics (SRPT) Down 30.3% Since Last Earnings Report: Can It Rebound?

Jazz (JAZZ) Down 9.2% Since Last Earnings Report: Can It Rebound?
ALNY

Zacks

23 days ago

Jazz (JAZZ) Down 9.2% Since Last Earnings Report: Can It Rebound?

Biotech Stock Roundup: SAVA Dives on Setback, ALNY Up on Update & More
ALNY

Zacks

24 days ago

Biotech Stock Roundup: SAVA Dives on Setback, ALNY Up on Update & More

Alnylam (ALNY) Surges 11.8%: Is This an Indication of Further Gains?
ALNY

Zacks

a month ago

Alnylam (ALNY) Surges 11.8%: Is This an Indication of Further Gains?

ALNY

MT Newswires

a month ago

JPMorgan Upgrades Alnylam Pharmaceuticals to Overweight From Neutral, Adjusts Price Target to $328 From $280

Alnylam Pharmaceuticals (NasdaqGS:ALNY) Sees 17% Weekly Gain As Vutrisiran Faces FDA Decision
ALNY

Simply Wall St.

a month ago

Alnylam Pharmaceuticals (NasdaqGS:ALNY) Sees 17% Weekly Gain As Vutrisiran Faces FDA Decision

Alnylam price target raised to $338 from $300 at Scotiabank
ALNY

TipRanks

a month ago

Alnylam price target raised to $338 from $300 at Scotiabank

ALNY

Morningstar Research

a month ago

Analyst Report: Alnylam Pharmaceuticals, Inc.

Alnylam Jumps As A New Approval Sets Up Its Next Battle With Pfizer, BridgeBio
ALNY

Investor's Business Daily

a month ago

Alnylam Jumps As A New Approval Sets Up Its Next Battle With Pfizer, BridgeBio

ALNY

MT Newswires

a month ago

Sector Update: Health Care Stocks Retreat Late Afternoon

Alnylam challenges Pfizer and BridgeBio with FDA nod for ATTR-CM drug
ALNY

Pharmaceutical Technology

a month ago

Alnylam challenges Pfizer and BridgeBio with FDA nod for ATTR-CM drug

Alnylam Stock Jumps After the FDA Approves Its Heart Drug
ALNY

The Wall Street Journal

a month ago

Alnylam Stock Jumps After the FDA Approves Its Heart Drug

Alnylam Gets FDA Nod for Expanded Use of Amvuttra in Cardiomyopathy
ALNY

Zacks

a month ago

Alnylam Gets FDA Nod for Expanded Use of Amvuttra in Cardiomyopathy

BioMarin (BMRN) Up 4.2% Since Last Earnings Report: Can It Continue?
ALNY

Zacks

a month ago

BioMarin (BMRN) Up 4.2% Since Last Earnings Report: Can It Continue?

Alnylam Heart Drug Approval Sets Up Challenge With Pfizer
ALNY

Bloomberg

a month ago

Alnylam Heart Drug Approval Sets Up Challenge With Pfizer

ALNY

MT Newswires

a month ago

Sector Update: Health Care

ALNY

MT Newswires

a month ago

RBC Adjusts Price Target on Alnylam Pharmaceuticals to $330 From $310, Maintains Outperform Rating

ALNY

MT Newswires

a month ago

Alnylam Pharmaceuticals Recieives US FDA Approval for ATTR-CM Drug

Alnylam Announces FDA Approval of AMVUTTRA® (vutrisiran), the First RNAi Therapeutic to Reduce Cardiovascular Death, Hospitalizations and Urgent Heart Failure Visits in Adults with ATTR Amyloidosis with Cardiomyopathy (ATTR-CM)
ALNY

Business Wire

a month ago

Alnylam Announces FDA Approval of AMVUTTRA® (vutrisiran), the First RNAi Therapeutic to Reduce Cardiovascular Death, Hospitalizations and Urgent Heart Failure Visits in Adults with ATTR Amyloidosis with Cardiomyopathy (ATTR-CM)

Alnylam drug gets long-awaited FDA approval in deadly heart disease
ALNY

BioPharma Dive

a month ago

Alnylam drug gets long-awaited FDA approval in deadly heart disease

Alnylam Rallies 62% in a Year: Can the Stock Maintain This Momentum?
ALNY

Zacks

a month ago

Alnylam Rallies 62% in a Year: Can the Stock Maintain This Momentum?

Alnylam to Webcast Presentation at Stifel 2025 Virtual CNS Forum
ALNY

Business Wire

a month ago

Alnylam to Webcast Presentation at Stifel 2025 Virtual CNS Forum

Dr. Phillip A. Sharp Retirement From Alnylam Pharmaceuticals (NasdaqGS:ALNY) Board Announced
ALNY

Simply Wall St.

a month ago

Dr. Phillip A. Sharp Retirement From Alnylam Pharmaceuticals (NasdaqGS:ALNY) Board Announced

High Growth Tech Stocks Leading The US Market
ALNY

Simply Wall St.

a month ago

High Growth Tech Stocks Leading The US Market

Alnylam Announces Retirement of Longtime Board Member, Dr. Phillip A. Sharp, Company Co-Founder and Industry Luminary
ALNY

Business Wire

a month ago

Alnylam Announces Retirement of Longtime Board Member, Dr. Phillip A. Sharp, Company Co-Founder and Industry Luminary

ALNY

Thomson Reuters StreetEvents

2 months ago

Q4 2024 Vir Biotechnology Inc Earnings Call

Alnylam Highlights Significant Pipeline Progress and Platform Innovation at R&D Day
ALNY

Business Wire

2 months ago

Alnylam Highlights Significant Pipeline Progress and Platform Innovation at R&D Day

ALNY

Morningstar Research

2 months ago

Analyst Report: Alnylam Pharmaceuticals, Inc.

Alnylam Pharmaceuticals (ALNY): Among the Oversold Biotech Stocks to Buy Now
ALNY

Insider Monkey

2 months ago

Alnylam Pharmaceuticals (ALNY): Among the Oversold Biotech Stocks to Buy Now

ALNY

MT Newswires

2 months ago

Alnylam Pharmaceuticals Insider Sold Shares Worth $787,904, According to a Recent SEC Filing

ALNY

MT Newswires

2 months ago

Alnylam Pharmaceuticals Insider Sold Shares Worth $531,448, According to a Recent SEC Filing

ALNY

MT Newswires

2 months ago

Alnylam Pharmaceuticals Insider Sold Shares Worth $309,527, According to a Recent SEC Filing

SNY and REGN's Dupixent sBLA for Skin Disease Gets FDA's Priority Tag
ALNY

Zacks

2 months ago

SNY and REGN's Dupixent sBLA for Skin Disease Gets FDA's Priority Tag

ALNY

Morningstar Research

2 months ago

Analyst Report: Alnylam Pharmaceuticals, Inc.

Alnylam Q4 Earnings Beat Estimates, Product Revenues Rise Y/Y
ALNY

Zacks

2 months ago

Alnylam Q4 Earnings Beat Estimates, Product Revenues Rise Y/Y

ALNY

MT Newswires

2 months ago

RBC Raises Price Target on Alnylam Pharmaceuticals to $310 From $300, Keeps Outperform Rating

Alnylam Pharmaceuticals Full Year 2024 Earnings: EPS Misses Expectations
ALNY

Simply Wall St.

2 months ago

Alnylam Pharmaceuticals Full Year 2024 Earnings: EPS Misses Expectations

Alnylam Pharmaceuticals Inc (ALNY) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and ...
ALNY

GuruFocus.com

2 months ago

Alnylam Pharmaceuticals Inc (ALNY) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and ...

ALNY

Thomson Reuters StreetEvents

2 months ago

Q4 2024 Alnylam Pharmaceuticals Inc Earnings Call

Alnylam (ALNY) Reports Q4 Earnings: What Key Metrics Have to Say
ALNY

Zacks

2 months ago

Alnylam (ALNY) Reports Q4 Earnings: What Key Metrics Have to Say

Alnylam Pharmaceuticals (ALNY) Beats Q4 Earnings and Revenue Estimates
ALNY

Zacks

2 months ago

Alnylam Pharmaceuticals (ALNY) Beats Q4 Earnings and Revenue Estimates

ALNY

MT Newswires

2 months ago

Alnylam Pharmaceuticals Swings to Q4 Earnings, Revenue Rises

ALNY

Associated Press Finance

2 months ago

Alnylam: Q4 Earnings Snapshot

Alnylam Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results and Highlights Recent Period Progress
ALNY

Business Wire

2 months ago

Alnylam Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results and Highlights Recent Period Progress

Biogen's Q4 Earnings & Sales Beat, 2025 EPS Guidance Disappoints
ALNY

Zacks

2 months ago

Biogen's Q4 Earnings & Sales Beat, 2025 EPS Guidance Disappoints

ILMN vs. ALNY: Which Stock Is the Better Value Option?
ALNY

Zacks

2 months ago

ILMN vs. ALNY: Which Stock Is the Better Value Option?

Will These 5 Biotech Bigwig Stocks Surpass Q4 Earnings Forecast?
ALNY

Zacks

2 months ago

Will These 5 Biotech Bigwig Stocks Surpass Q4 Earnings Forecast?

Ahead of Alnylam (ALNY) Q4 Earnings: Get Ready With Wall Street Estimates for Key Metrics
ALNY

Zacks

2 months ago

Ahead of Alnylam (ALNY) Q4 Earnings: Get Ready With Wall Street Estimates for Key Metrics

Moderna (MRNA) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 Release
ALNY

Zacks

2 months ago

Moderna (MRNA) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 Release

Alnylam Pharmaceuticals (ALNY) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
ALNY

Zacks

2 months ago

Alnylam Pharmaceuticals (ALNY) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

Are Medical Stocks Lagging Guardant Health (GH) This Year?
ALNY

Zacks

2 months ago

Are Medical Stocks Lagging Guardant Health (GH) This Year?

Pfizer's Q4 Earnings Beat Estimates, Non-Covid Drugs Drive Sales
ALNY

Zacks

2 months ago

Pfizer's Q4 Earnings Beat Estimates, Non-Covid Drugs Drive Sales

Will Non-COVID Drugs Drive PFE's Top Line in Q4 Earnings?
ALNY

Zacks

3 months ago

Will Non-COVID Drugs Drive PFE's Top Line in Q4 Earnings?

Bet on These 4 Top-Performing Liquid Stocks for Solid Gains
ALNY

Zacks

3 months ago

Bet on These 4 Top-Performing Liquid Stocks for Solid Gains

Alnylam to Webcast Conference Call Discussing Fourth Quarter and Full Year 2024 Financial Results
ALNY

Business Wire

3 months ago

Alnylam to Webcast Conference Call Discussing Fourth Quarter and Full Year 2024 Financial Results

ALNY

MT Newswires

3 months ago

Alnylam Pharmaceuticals Insider Sold Shares Worth $14,988,720, According to a Recent SEC Filing

FDA Expands Label of AZN's Enhertu for New Breast Cancer Indication
ALNY

Zacks

3 months ago

FDA Expands Label of AZN's Enhertu for New Breast Cancer Indication

New Strong Buy Stocks for January 27th
ALNY

Zacks

3 months ago

New Strong Buy Stocks for January 27th

Exploring Three High Growth Tech Stocks In The United States
ALNY

Simply Wall St.

3 months ago

Exploring Three High Growth Tech Stocks In The United States

GILD vs. ALNY: Which Stock Is the Better Value Option?
ALNY

Zacks

3 months ago

GILD vs. ALNY: Which Stock Is the Better Value Option?

Here's Why Alnylam Pharmaceuticals (ALNY) is a Strong Momentum Stock
ALNY

Zacks

3 months ago

Here's Why Alnylam Pharmaceuticals (ALNY) is a Strong Momentum Stock

ALNY

Morningstar Research

3 months ago

Analyst Report: Alnylam Pharmaceuticals, Inc.

Best Momentum Stocks to Buy for January 21st
ALNY

Zacks

3 months ago

Best Momentum Stocks to Buy for January 21st

Are Medical Stocks Lagging Alnylam Pharmaceuticals (ALNY) This Year?
ALNY

Zacks

3 months ago

Are Medical Stocks Lagging Alnylam Pharmaceuticals (ALNY) This Year?

New Strong Buy Stocks for January 21st
ALNY

Zacks

3 months ago

New Strong Buy Stocks for January 21st

ALNY Announces Preliminary 2024 Results, 2025 View & Pipeline Goals
ALNY

Zacks

3 months ago

ALNY Announces Preliminary 2024 Results, 2025 View & Pipeline Goals

Alnylam Announces Preliminary* Fourth Quarter and Full Year 2024 Global Net Product Revenues and Provides 2025 Combined Net Product Revenue Guidance and Pipeline Goals
ALNY

Business Wire

3 months ago

Alnylam Announces Preliminary* Fourth Quarter and Full Year 2024 Global Net Product Revenues and Provides 2025 Combined Net Product Revenue Guidance and Pipeline Goals

Alnylam to Webcast Presentation at 43rd Annual J.P. Morgan Healthcare Conference
ALNY

Business Wire

3 months ago

Alnylam to Webcast Presentation at 43rd Annual J.P. Morgan Healthcare Conference

Exploring High Growth Tech Stocks in the US December 2024
ALNY

Simply Wall St.

4 months ago

Exploring High Growth Tech Stocks in the US December 2024

Is Alnylam Pharmaceuticals (ALNY) Stock Outpacing Its Medical Peers This Year?
ALNY

Zacks

4 months ago

Is Alnylam Pharmaceuticals (ALNY) Stock Outpacing Its Medical Peers This Year?

Is Alnylam Pharmaceuticals, Inc. (ALNY) the Best Performing Biotech Stock in 2024?
ALNY

Insider Monkey

4 months ago

Is Alnylam Pharmaceuticals, Inc. (ALNY) the Best Performing Biotech Stock in 2024?

The Zacks Analyst Blog Highlights Sarepta Therapeutics, ADMA Biologics, Exelixis and Alnylam
ALNY

Zacks

4 months ago

The Zacks Analyst Blog Highlights Sarepta Therapeutics, ADMA Biologics, Exelixis and Alnylam

4 Biotech Stocks Most Wall Street Analysts Are Bullish About
ALNY

Zacks

4 months ago

4 Biotech Stocks Most Wall Street Analysts Are Bullish About

ALNY

MT Newswires

4 months ago

Alnylam Pharmaceuticals Insider Sold Shares Worth $439,760, According to a Recent SEC Filing

CRDF Stock Soars on Robust Efficacy Data From Colorectal Cancer Study
ALNY

Zacks

4 months ago

CRDF Stock Soars on Robust Efficacy Data From Colorectal Cancer Study

What Makes Alnylam (ALNY) a New Buy Stock
ALNY

Zacks

5 months ago

What Makes Alnylam (ALNY) a New Buy Stock

Is Sensus Healthcare (SRTS) Outperforming Other Medical Stocks This Year?
ALNY

Zacks

5 months ago

Is Sensus Healthcare (SRTS) Outperforming Other Medical Stocks This Year?

Why Is Alnylam Pharmaceuticals, Inc. (ALNY) Among the Best High Growth Healthcare Stocks to Invest In Now?
ALNY

Insider Monkey

5 months ago

Why Is Alnylam Pharmaceuticals, Inc. (ALNY) Among the Best High Growth Healthcare Stocks to Invest In Now?

ALNY

MT Newswires

5 months ago

Mirae Asset Downgrades Alnylam Pharmaceuticals to Hold, Price Target is $236

ALNY

MT Newswires

5 months ago

Alnylam Pharmaceuticals Insider Sold Shares Worth $422,144, According to a Recent SEC Filing

ALNY

MT Newswires

5 months ago

Alnylam Pharmaceuticals Insider Sold Shares Worth $1,309,853, According to a Recent SEC Filing

Alnylam to Webcast Presentation at Piper Sandler 36th Annual Healthcare Conference
ALNY

Business Wire

5 months ago

Alnylam to Webcast Presentation at Piper Sandler 36th Annual Healthcare Conference

Kronos, Idorsia plan layoffs; PTC shelves ALS drug
ALNY

BioPharma Dive

5 months ago

Kronos, Idorsia plan layoffs; PTC shelves ALS drug

FDA Begins Review of Alnylam's sNDA for Expanded Amvuttra Use
ALNY

Zacks

5 months ago

FDA Begins Review of Alnylam's sNDA for Expanded Amvuttra Use

BridgeBio Catapults After Snagging Approval For Its Rival To Pfizer's Heart Drug
ALNY

Investor's Business Daily

5 months ago

BridgeBio Catapults After Snagging Approval For Its Rival To Pfizer's Heart Drug

Exploring Three High Growth Tech Stocks In The United States
ALNY

Simply Wall St.

5 months ago

Exploring Three High Growth Tech Stocks In The United States

Share on Social Networks: